Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
Joint Authors
Di Pede, Chiara
Congedi, Sabrina
Rossin, Sara
Divisic, Antuan
De Gregorio, Alesandra
Agosto, Caterina
Catalano, Igor
Mazza, Alessandro
Sartori, Leonardo
Benini, Franca
Masiero, Stefano
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-09-22
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate.
Further research is needed to assess its safety and efficacy as a treatment option for FD in the paediatric population.
American Psychological Association (APA)
Di Pede, Chiara& Congedi, Sabrina& Rossin, Sara& Divisic, Antuan& De Gregorio, Alesandra& Agosto, Caterina…[et al.]. 2016. Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia. Case Reports in Pediatrics،Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1102360
Modern Language Association (MLA)
Di Pede, Chiara…[et al.]. Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia. Case Reports in Pediatrics No. 2016 (2016), pp.1-6.
https://search.emarefa.net/detail/BIM-1102360
American Medical Association (AMA)
Di Pede, Chiara& Congedi, Sabrina& Rossin, Sara& Divisic, Antuan& De Gregorio, Alesandra& Agosto, Caterina…[et al.]. Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia. Case Reports in Pediatrics. 2016. Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1102360
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1102360
